Kinnate Biopharma Inc. Quarterly Assets in USD from Q4 2020 to Q4 2023

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Kinnate Biopharma Inc. quarterly Assets history and growth rate from Q4 2020 to Q4 2023.
Kinnate Biopharma Inc. Assets for the quarter ending December 31, 2023 was $174M, a 37.7% decline year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q4 2023	$174M	-$105M	-37.7%	Dec 31, 2023	10-K	2024-03-28
Q3 2023	$191M	-$111M	-36.9%	Sep 30, 2023	10-Q	2023-11-09
Q2 2023	$216M	-$108M	-33.3%	Jun 30, 2023	10-Q	2023-08-08
Q1 2023	$244M	-$105M	-30%	Mar 31, 2023	10-Q	2023-05-11
Q4 2022	$279M	-$88M	-24%	Dec 31, 2022	10-K	2024-03-28
Q3 2022	$302M	-$84.2M	-21.8%	Sep 30, 2022	10-Q	2022-11-10
Q2 2022	$324M	-$80.8M	-20%	Jun 30, 2022	10-Q	2022-08-11
Q1 2022	$349M	-$37.7M	-9.77%	Mar 31, 2022	10-Q	2022-05-12
Q4 2021	$367M	-$33.7M	-8.42%	Dec 31, 2021	10-K	2023-03-15
Q3 2021	$386M			Sep 30, 2021	10-Q	2021-11-10
Q2 2021	$405M			Jun 30, 2021	10-Q	2021-08-16
Q1 2021	$386M			Mar 31, 2021	10-Q	2021-05-17
Q4 2020	$401M			Dec 31, 2020	10-K	2022-03-28

* An asterisk sign (*) next to the value indicates that the value is likely invalid.